Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Anticancer Research|November 20, 2001
Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysisG Curigliano, G Ferretti, G Flamini, et al.
Journal of Cancer Research and Clinical Oncology|November 20, 2012
Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumoursG Spitaleri, R Berardi, C Pierantoni, et al.
British Journal of Cancer|February 13, 2014
Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoidsF Toffalorio, E Belloni, M Barberis, et al.
International Journal of Cancer|August 5, 2000
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC)C Boni, G Bisagni, L Savoldi, et al.
The Pharmacogenomics Journal|November 11, 2009
Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancerF Toffalorio, E Giovannetti, T De Pas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2009
Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancerG Spitaleri, D V Matei, G Curigliano, et al.
Anticancer Research|February 26, 2004
Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinomaN Fazio, F Orsi, R F Grasso, et al.
Chemotherapy|May 21, 2011
Optimizing clinical care in patients with advanced soft tissue sarcoma: a phase II study of a new schedule of high-dose continuous infusion ifosfamide and doxorubicin combinationT De Pas, G Rosati, G Spitaleri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancerT De Pas, F de Braud, R Danesi, et al.
British Journal of Cancer|May 5, 2011
Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II studyH Joensuu, F De Braud, G Grignagni, et al.
Pageof 4